1 Laboratoire de Biologie du Développement, UMR-CNRS 7622, Université Pierre et Marie Curie, boîte 24, 4 place Jussieu, 75252 Paris, CEDEX 5, France
2 Centre de Recherche de Biochimie Macromoléculaire, CNRS FRE 2593, 1919 Route de Mende, 34293 Montpellier, CEDEX 5, France
3 Signal Transduction and Plasticity in the Nervous System, INSERM U-536, Université Pierre et Marie Curie, Institut du Fer-à-Moulin, 17 rue du Fer-à-Moulin, 75005 Paris, France
* Author for correspondence (e-mail: jessus{at}ccr.jussieu.fr)
Accepted 9 March 2005
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Aurora-A, Cdc2, PP1, PP2A, Xenopus oocyte
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Aurora-A and -B protein kinases are important factors in cell division control, Aurora-A being involved in spindle formation (Carmena and Earnshaw, 2003). Aurora-A plays various functions during Xenopus oocyte meiotic divisions, as the control of the first meiotic spindle (Castro et al., 2003
) and more surprisingly the regulation of the polyadenylation of Mos mRNA (Mendez et al., 2000
; Sarkissian et al., 2004
). It has been shown that during oocyte maturation, active MPF is necessary and sufficient to induce indirectly Aurora-A phosphorylation and activation (Frank-Vaillant et al., 2000
; Maton et al., 2003
). Active Cdc2 could activate either an unknown kinase specific to Aurora-A or could allow Aurora-A to autophosphorylate and to autoactivate by recruiting an Aurora-A adapter or by inhibiting a specific phosphatase. Indeed, Aurora-A has two known activating partners, one localized in the centrosome, Ajuba (Hirota et al., 2003
), and the other one in the mitotic spindle, TPX2 (Tsai et al., 2003
; Eyers et al., 2003
). Both of them stimulate autophosphorylation and autoactivation of Aurora-A on Thr295 in Xenopus (Thr288 in human Aurora-A) and protect the enzyme from inactivation by phosphatases (Tsai et al., 2003
; Eyers et al., 2003
). Recent studies reported that activation of Aurora-A kinase is negatively regulated by PP1. It was shown that the autoactivation of Aurora-A is regulated through a novel mechanism: Aurora-A autoactivation would be continuously antagonized by PP1 activity (Tsai et al., 2003
). In the presence of regulatory proteins, such as TPX2, Ajuba or the PP1 inhibitor-2 (I-2), the dephosphorylation of active Aurora-A would be prevented (Hirota et al., 2003
; Tsai et al., 2003
; Eyers et al., 2003
; Satinover et al., 2004
). However, all these studies were conducted with bacterially expressed Aurora-A, which is activated by autophosphorylation. Whether this mechanism is operative in vivo remains to be shown, particularly during Xenopus oocyte meiotic maturation. In resting prophase oocytes, Aurora-A is kept inactive; it is activated during oocyte maturation following Cdc2 activation (Frank-Vaillant et al., 2000
; Maton et al., 2003
).
In this study, we asked two main questions. The first concerns the identification of the okadaic acid-sensitive phosphatases that negatively regulate Cdc2 and Aurora-A activation in Xenopus oocyte. The second relates to their regulatory role: does the activation of Cdc2 and Aurora-A depend solely on the inhibition of these phosphatases or does it require additional stimulation of regulatory kinases? To address these questions, we used microcystin beads that allow the generation of Xenopus oocyte extracts depleted in PP2A and retaining PP1.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Purification of recombinant proteins
The 21 N-terminal amino acids of wild-type histone H3 fused with glutathione S-transferase (GST) were cloned into pGEX vector (Scrittori et al., 2001), expressed in bacteria and purified as described (Maton et al., 2003
). Recombinant GST-p21cip1 was expressed in bacteria and purified as described (Frank-Vaillant et al., 1999
). Rat DARPP-32 was expressed in bacteria and phosphorylated on Thr34 by PKA to a stoichiometry of one as described (Desdouits et al., 1995
).
Prophase oocyte extracts
Fully grown Xenopus oocytes (prophase) or fully grown oocytes incubated overnight in 1 µM progesterone (metaphase II-arrested oocytes) were isolated and lysed at 4°C in four volumes of extraction buffer (EB) (80 mM ß-glycerophosphate, pH 7.3, 20 mM EGTA, 15 mM MgCl2, 1 mM DTT), supplemented with protease inhibitor mixture (Sigma, P8340). Lysates were centrifuged at 15,000 g at 4°C for 15 minutes. Supernatants (named `oocyte extracts') were incubated at 30°C in the presence or absence of an ATP-regenerating system (10 mM creatine phosphate, 80 mg/ml creatine phosphokinase, 1 mM ATP, 1 mM MgCl2) with or without 0.1 or 1 µM okadaic acid (ICN) or 0.1 or 1 µM microcystin-LR. Samples were collected at indicated times for Western blot analysis and kinase assays.
PP2A-depleted oocyte extracts
Extracts from 15 oocytes were incubated at 4°C for 1 hour with 10 µl microcystin-agarose beads (Upstate) or sepharose beads (Pharmacia) (v/v in EB). After centrifugation, the supernatant was collected and in some experiments, the incubation with beads was repeated once or twice. The bead pellets were resuspended in Laemmli buffer and analysed by western blotting. The supernatants were either collected for western blotting or processed for further incubation.
Western blotting
Samples equivalent to two oocytes were separated by a 12.5% SDS-PAGE Anderson system (Anderson et al., 1973) and transferred to nitrocellulose filters (Schleicher and Schuell) using a semi-dry blotting system (Millipore). The rabbit anti-Xenopus Aurora-A polyclonal antibody, the goat polyclonal antibody raised against Xenopus cyclin B2 and the guinea pig polyclonal antibodies directed against the 35 kDa catalytic subunit (C35) and the 65 kDa regulatory subunit (R65) of PP2A were described (Castro et al., 2002
; De Smedt et al., 2000; Bosch et al., 1995
) respectively. The mouse monoclonal antibody directed against the catalytic subunit of PP1 was purchased from Transduction Laboratories. The rabbit polyclonal antibody directed against Aurora-A phosphorylated on Thr295 (Thr288 in human Aurora-A), P-Aurora-A, was purchased from Cell Signaling. The mouse monoclonal antibodies directed against DARPP-32 and the DARPP-32 phosphorylated on Thr34 (P-DARPP-32) were a kind gift of Paul Greengard (Rockefeller University, New York, NY) and have been described (Snyder et al., 1992
). The primary antibodies were detected with appropriate horseradish peroxidase-conjugated second antibodies (Jackson ImmunoResearch Laboratories) and the western blot Chemoluminescence Renaissance kit from Perkin Elmer Life Sciences.
Kinase assays
To measure Cdc2 kinase activity, histone H1 assays were performed on p13suc1 sepharose pull-down extracts (equivalent to three oocytes) as described (Jessus et al., 1991), in the presence of 1 µCi [
-32P]ATP (ICN), 100 µM ATP and 0.2 mg/ml histone H1 (Boehringer) in kinase buffer (50 mM Tris-HCl, pH 7.2, 15 mM MgCl2, 5 mM EGTA, 1 mM DTT).
Histone H3 kinase activity of Aurora-A was assayed in immunoprecipitates (equivalent to ten oocytes), incubated for 30 minutes at 30°C in the presence of kinase buffer containing 3 µCi [-32P]ATP (ICN), 50 µM ATP and 0.5 mg/ml recombinant H3-GST, as described (Maton et al., 2003
). Kinase reactions were stopped by adding Laemmli buffer (Laemmli, 1970
) and boiling. After electrophoresis and autoradiography, the bands corresponding to histone H1 and histone H3 peptide were excised and the associated radioactivity was measured in a Wallace 1409 scintillation counter.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
Removal of PP2A is sufficient to lead to Cdc2 and Aurora-A activation
Kinase activity of Cdc2 and Aurora-A was assayed in control extracts and in PP2A-depleted extracts after microcystin beads incubation (Fig. 3). In control extracts, activation of both kinases as well as phosphorylation of cyclin B2 and Aurora-A depend on the addition of okadaic acid together with an ATP-regenerating system (Fig. 3), as previously reported (Karaiskou et al., 1999; Maton et al., 2003
; Karaiskou et al., 1998
). In contrast, in PP2A-depleted extracts, all these events occurred spontaneously in the presence of an ATP-regenerating system, without requiring addition of okadaic acid: Cdc2 and Aurora-A kinases were activated (Fig. 3A) and cyclin B2 and Aurora-A underwent activatory phosphorylations (Fig. 3B). In some experiments, a partial kinase activation of Cdc2 and Aurora-A occurred spontaneously in PP2A-depleted extracts without any ATP addition, probably due to the presence of traces of endogenous ATP (Fig. 3). Addition of okadaic acid neither affected the time-course nor the level of the activation and phosphorylation of both kinases in PP2A-depleted extracts (Fig. 3). Therefore, removal of PP2A is sufficient to induce Cdc2 and Aurora-A activation, provided that ATP is present and despite the presence of PP1. This result suggests that a major negative control is exerted by PP2A on Cdc2 and Aurora-A in oocyte extracts. Once this negative regulator is removed, endogenous kinases are able to turn on the activatory system without any additional stimulation.
|
|
Inhibition of PP1 does not modify Cdc2 and Aurora-A activation in the absence of PP2A
PP1 has been shown to regulate negatively recombinant Aurora-A autophosphorylation (Katayama et al., 2001). In contrast, PP1 was shown to regulate Cdc2 activation positively, through Cdc25 dephosphorylation on the inhibitory residue Thr287 (Margolis et al., 2003
). As PP1 is present in PP2A-depleted extracts, it would then favour Cdc2 activation and impair Aurora-A activation. To further explore the role(s) of PP1 in the pathway leading to the activation of these kinases, its phosphatase activity was inhibited by adding the specific protein inhibitor, P-DARPP-32 (Walaas et al., 1983
). This protein is not expressed in Xenopus oocytes. The inhibitory activity of DARPP-32 depends on its phosphorylation by PKA (Hemmings et al., 1984
). Conversely, DARPP-32 is dephosphorylated and inactivated by PP2A and PP2B (Hemmings et al., 1990
). We therefore used a recombinant phosphorylated form of DARPP32, P-DARPP32. In control extracts, Cdc2 and Aurora-A activation was induced by addition of okadaic acid, in the presence or in the absence of P-DARPP-32 (Figs 5, 6). Cdc2 and Aurora-A kinase activation (Fig. 5), as well as cyclin B2 and Aurora-A phosphorylation (Fig. 6A,B) were not affected by the presence of P-DARPP-32.
|
|
The presence of exogenously added DARPP-32, as well as its phosphorylation level, were analysed by western blotting using specific antibodies, recognizing either all the forms of DARPP-32 or its phosphorylated form. We observed that in control extracts, P-DARPP-32 was dephosphorylated within 30 minutes in the absence of okadaic acid, whereas the phosphorylated form was stable over 2 hours in the presence of okadaic acid (Fig. 6B). This result indicates that active PP2A present in crude extracts dephosphorylates and therefore inactivates DARPP-32. In the presence of okadaic acid, DARPP-32 phosphorylation remained stable, owing to PP2A inhibition, and thus capable of inhibiting PP1. The okadaic acid concentration used in our experiments is probably not sufficient to fully abolish PP1 activity in crude extracts (Goris et al., 1989; Karaiskou et al., 1998
). Our results therefore show that full inhibition of PP1 by P-DARPP-32 in okadaic acid-treated extracts does not affect Cdc2 and Aurora-A activation (Fig. 5, Fig. 6A,B).
We then analysed the effect of PP1 inhibition by P-DARPP32 in PP2A-depleted extracts. As expected, DARPP-32 phosphorylation was stable in such extracts, owing to the absence of PP2A, and the inhibitor was therefore active towards PP1 all over the incubation period (Fig. 6D). In PP2A-depleted extracts, Cdc2 and Aurora-A activation occurred spontaneously within 1 hour in the presence of ATP (Fig. 5, Fig. 6C). Inhibition of PP1 by P-DARPP-32 did not modify the time-course, the activation level and the phosphorylation level of Cdc2, cyclin B2 and Aurora-A (Fig. 5, Fig. 6C,D). Under such conditions, it is however impossible to know whether PP1 inhibition is sufficient to induce Aurora-A activation as Cdc2 is activated by PP2A removal and is able to trigger Aurora-A activation indirectly.
To investigate whether PP1 inhibition is sufficient to promote Aurora-A activation independently of Cdc2 and PP2A, extracts were depleted in PP2A in the presence of p21Cip1 (note again in Fig. 7 that p21Cip1 was non-specifically recognized by PP2A antibodies in western blots, giving rise to a 67 kDa p21Cip1 band and a 36 kDa cleavage product, probably GST). Under such conditions, extracts are devoid of PP2A but retain PP1, and Cdc2 activation is prevented by the p21Cip1 inhibitor (Fig. 7). P-DARPP-32 was added in such extracts. Inhibition of PP1 by P-DARPP-32 is unable to trigger phosphorylation on Thr295 and activation of Aurora-A, even in the presence of ATP (Fig. 7). Then, it can be concluded that the regulation of Aurora-A activation is driven by Cdc2 activity and is independent of PP1.
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
More than a decade ago, it was proposed that PP2A, a major Ser/Thr phosphatase present in the Xenopus oocyte, is a negative regulator of Cdc2 activation (Hermann et al., 1988; Lee et al., 1994
). Our results based on the use of PP2A-depleted extracts unequivocally show that PP2A corresponds to the okadaic acid-sensitive phosphatase that antagonizes the autoamplification of Cdc2. The simple addition of ATP to PP2A-depleted extracts allows Cdc2 activation. Inhibition of PP1 by the specific inhibitor P-DARPP-32, does not affect Cdc2 activation. This result means that the activation of latent kinase(s) antagonized by PP2A is sufficient for the activation of Cdc25C, the phosphatase necessary for Cdc2 autoamplification. It is well established that activity of Cdc25 in Xenopus oocytes is positively regulated by Cdc2 kinase and Plx1 (Kumagai and Dunphy, 1996
; Karaiskou et al., 1999
; Abrieu et al., 1998
). Plx1 activity is under the control of Cdc2 (Karaiskou et al., 1999
; Abrieu et al., 1998
; Erikson et al., 2004
). It can therefore be concluded that in prophase-arrested oocytes, PP2A permanently antagonizes the activity of these kinases. All these results would neatly explain why a threshold amount of active Cdc2 is sufficient to initiate the autoamplification loop: the presence of a starter amount of active Cdc2 would activate Plx1; both Cdc2 and Plx1 would then overcome the action of PP2A and prevent it dephosphorylating Cdc25. Therefore, the autoamplification loop can be initiated in two ways: PP2A inhibition and/or an increase in Cdc2 activity above a threshold level. The pathway selected by progesterone, the physiological inducer of M-phase entry in Xenopus oocytes, remains to be determined. In any case, our experimental approach definitively shows that PP1 is not the okadaic acid-sensitive phosphatase preventing Cdc2 autoamplification.
As described in the introduction, the phosphorylation and the kinase activation of Aurora-A in Xenopus oocytes requires the previous activation of Cdc2 kinase both in vivo and in vitro (Frank-Vaillant et al., 2000; Maton et al., 2003
). The link between Cdc2 and Aurora-A remains unknown but it does not involve a direct phosphorylation of Aurora-A by Cdc2 (Maton et al., 2003
). An interesting model for Aurora-A has recently been proposed (Tsai et al., 2003
; Eyers et al., 2003
); it indicates that Xenopus Aurora-A is able to autoactivate by phosphorylating its Thr295 residue (Thr288 in humans). Aurora-A contains consensus sequences involved in PP1 catalytic subunit binding and autophosphorylation of a recombinant form of Aurora-A is antagonized by PP1 in vitro (Katayama et al., 2001
). Interaction with new regulators, such as TPX2, Ajuba or the PP1 inhibitor-2 (I-2) prevents the antagonistic action of PP1 and leads to Aurora-A activation (Hirota et al., 2003
; Eyers et al., 2003
; Satinover et al., 2004
). Then Aurora-A activation could simply rely on PP1 inhibition. Therefore it was important to determine whether this mechanism involving PP1 is operative in vivo and/or in vitro in oocyte extracts and whether it is independent of Cdc2 activity.
Our results show that removal of PP2A from oocyte extracts by microcystin beads is sufficient to lead to Aurora-A activation, despite the presence of PP1. Removal of PP2A and inhibition of PP1 by the DARPP-32 inhibitor does not modify Aurora-A activation. Under these conditions, we have shown that the direct consequence of PP2A removal is Cdc2 activation, and that active Cdc2 is necessary for Aurora-A activation. Cdc2 activity is absolutely required for Aurora-A activation in PP2A-depleted extracts, whether PP1 is active or inhibited by P-DARPP-32. Moreover, our results unambiguously show that the inhibition of PP1 by DARPP-32 is not sufficient to induce phosphorylation and activation of Aurora-A in the absence of Cdc2 activity.
In Xenopus oocytes, Aurora-A activation depends on activation of a stimulatory pathway initiated by Cdc2, which does not require PP1 inhibition. Whether this pathway involves proteins already known to play a role in Aurora-A activation in mitotic cells, such as TPX2, Ajuba or I-2, and whether it implicates Aurora-A autophosphorylation or the recruitment of new protein kinases, remain to be explored. Our results do not support the view that the regulation of Aurora-A activity in resting prophase oocytes is regulated by a permanent autophosphorylation/dephosphorylation turnover.
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Abrieu, A., Brassac, T., Galas, S., Fisher, D., Labbe, J. C. and Doree, M. (1998). The Polo-like kinase Plx1 is a component of the MPF amplification loop at the G2/M-phase transition of the cell cycle in Xenopus eggs. J. Cell Sci. 111, 1751-1757.
Anderson, C. W., Baum, P. R. and Gesteland, R. F. (1973). Processing of adenovirus 2-induced proteins. J. Virol. 12, 241-252.[Medline]
Bialojan, C. and Takai, A. (1988). Inhibitory Effect of a Marine-Sponge Toxine, okadaic acid, on Proteine Phosphatase. Biochem. J. 256, 283-290.[Medline]
Bosch, M., Cayla, X., van Hoof, C., Hemmings, B. A., Ozon, R., Merlevede, W. and Goris, J. (1995). The PR55 and PR65 subunits of protein phosphatase 2A from Xenopus laevis. molecular cloning and developmental regulation of expression. Eur. J. Biochem. 230, 1037-1045.[Abstract]
Carmena, M. and Earnshaw, W. C. (2003). The cellular geography of aurora kinases. Nat. Rev. Mol. Cell. Biol. 4, 842-854.[CrossRef][Medline]
Castro, A., Arlot-Bonnemains, Y., Vigneron, S., Labbe, J. C., Prigent, C. and Lorca, T. (2002). APC/Fizzy-Related targets Aurora-A kinase for proteolysis. EMBO Rep. 3, 457-462.
Castro, A., Mandart, E., Lorca, T. and Galas, S. (2003). Involvement of Aurora A Kinase during Meiosis I-II transition in Xenopus oocytes. J. Biol. Chem. 278, 2236-2241.
Cohen, P. (1989). The structure and regulation of protein phosphatases. Ann. Rev. Biochem. 58, 453-508.[CrossRef][Medline]
De Smedt, V., Poulhe, R., Cayla, X., Dessauge, F., Karaiskou, A., Jessus, C. and Ozon, R. (2002). Thr-161 phosphorylation of monomeric Cdc2. Regulation by protein phosphatase 2C in Xenopus oocytes. J. Biol. Chem. 277, 28592-28600.
Desdouits, F., Cheetham, J. J., Huang, H. B., Kwon, Y. G., da Cruz e Silva, E. F., Denefle, P., Ehrlich, M. E., Nairn, A. C., Greengard, P. and Girault, J. A. (1995). Mechanism of inhibition of protein phosphatase 1 by DARPP-32: studies with recombinant DARPP-32 and synthetic peptides. Biochem. Biophys. Res. Com. 206, 652-658.[CrossRef][Medline]
Duckworth, B. C., Weaver, J. S. and Ruderman, J. V. (2002). G2 arrest in Xenopus oocytes depends on phosphorylation of cdc25 by protein kinase A. Proc. Natl. Acad. Sci. USA 99, 16794-16799.
Dumortier, K., Hermann, J., Goris, J., Ozon, R. and Merlevede, W. (1987). Identification of protein phosphatases and their regulatory proteins in Xenopus laevis oocytes. Arch. Inter. Physiol. Biochim. 95, B197.
Erikson, E., Haystead, T. A., Qian, Y. W. and Maller, J. L. (2004). A feedback loop in the polo-like kinase activation pathway. J. Biol. Chem. 279, 32219-32224.
Eyers, P. A., Erikson, E., Chen, L. G. and Maller, J. L. (2003). A novel mechanism for activation of the protein kinase Aurora A. Curr. Biol. 13, 691-697.[CrossRef][Medline]
Felix, M. A., Cohen, P. and Karsenti, E. (1990). Cdc2 H1 kinase is negatively regulated by a type 2A phosphatase in the Xenopus early embryonic cell cycle: evidence from the effects of okadaic acid. EMBO J. 9, 675-668.[Abstract]
Frank-Vaillant, M., Jessus, C., Ozon, R., Maller, J. L. and Haccard, O. (1999). Two distinct mechanisms control the accumulation of Cyclin B1 and Mos in Xenopus oocytes in response to progesterone. Mol. Biol. Cell 10, 3279-3288.
Frank-Vaillant, M., Haccard, O., Thibier, C., Ozon, R., Arlot-Bonnemains, Y., Prigent, C. and Jessus, C. (2000). Progesterone regulates the accumulation and the activation of Eg2 kinase in Xenopus oocytes. J. Cell Sci. 113, 1127-1138.
Goris, J., Hermann, J., Hendrix, P., Ozon, R. and Merlevede, W. (1989). Okadaic acid, a specific protein phosphatase inhibitor, induces maturation and MPF formation in Xenopus laevis oocytes. FEBS Lett. 245, 91-94.[CrossRef][Medline]
Hemmings, H. C., Greengard, P., Tung, H. Y. L. and Cohen, P. (1984). DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310, 503-505.[Medline]
Hemmings, H. C., Jr, Nairn, A. C., Elliott, J. I. and Greengard, P. (1990). Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity. J. Biol. Chem. 265, 20369-20376.
Hermann, J., Cayla, X., Dumortier, K., Goris, J., Ozon, R. and Merlevede, W. (1988). Polycation stimulated protein phosphatase from Xenopus laevis oocytes. ATP mediated regulation of pNPP phosphatase activity. Eur. J. Biochem. 173, 17-25.[Abstract]
Hirota, T., Kunitoku, N., Sasayama, T., Marumoto, T., Zhang, D., Nitta, M., Hatakeyama, K. and Saya, H. (2003). Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 114, 585-598.[CrossRef][Medline]
Hochegger, H., Klotzbucher, A., Kirk, J., Howell, M., le Guellec, K., Fletcher, K., Duncan, T., Sohail, M. and Hunt, T. (2001). New B-type cyclin synthesis is required between meiosis I and II during Xenopus oocyte maturation. Development 128, 3795-3807.
Huchon, D., Ozon, R. and Demaille, J. G. (1981). Protein phosphatase-1 is involved in Xenopus oocyte maturation. Nature 294, 358-359.[CrossRef][Medline]
Izumi, T. and Maller, J. L. (1993). Elimination of Cdc2 phosphorylation sites in the Cdc25 phosphatase blocks initiation of M-phase. Mol. Biol. Cell 4, 1337-1350.[Abstract]
Izumi, T., Walker, D. H. and Maller, J. L. (1992). Periodic changes in phosphorylation of the Xenopus Cdc25 phosphatase regulate its activity. Mol. Biol. Cell 3, 927-939.[Abstract]
Jessus, C., Rime, H., Haccard, O., van Lint, J., Goris, J., Merlevede, W. and Ozon, R. (1991). Tyrosine phosphorylation of p34cdc2 and p42 during meiotic maturation of Xenopus oocyte. Antagonistic action of okadaic acid and 6-DMAP. Development 111, 813-820.[Abstract]
Karaiskou, A., Cayla, X., Haccard, O., Jessus, C. and Ozon, R. (1998). MPF amplification in Xenopus oocyte extracts depends on a two-step activation of cdc25 phosphatase. Exp. Cell Res. 244, 491-500.[CrossRef][Medline]
Karaiskou, A., Jessus, C., Brassac, T. and Ozon, R. (1999). Phosphatase 2A and polo kinase, two antagonistic regulators of cdc25 activation and MPF auto-amplification. J. Cell Sci. 112, 3747-3756.
Karaiskou, A., Dupre, A., Haccard, O. and Jessus, C. (2001). From progesterone to active Cdc2 in Xenopus oocytes: a puzzling signalling pathway. Biol. Cell 93, 35-46.[CrossRef][Medline]
Katayama, H., Zhou, H., Li, Q., Tatsuka, M. and Sen, S. (2001). Interaction and feedback regulation between STK15/BTAK/Aurora-A kinase and protein phosphatase 1 through mitotic cell division cycle. J. Biol. Chem. 276, 46219-46224.
Kumagai, A. and Dunphy, W. G. (1992). Regulation of the Cdc25 protein during the cell cycle in Xenopus extracts. Cell 70, 139-151.[CrossRef][Medline]
Kumagai, A. and Dunphy, W. G. (1996). Purification and molecular cloning of Plx1, a Cdc25-regulatory kinase from Xenopus egg extracts. Science 273, 1377-1380.[Abstract]
Kumagai, A., Yakowec, P. S. and Dunphy, W. G. (1998). 14-3-3 proteins act as negative regulators of the inducer Cdc25 in Xenopus egg extracts. Mol. Biol. Cell 9, 345-354.
Laemmli, U. K. (1970). Cleavage of structural proteins during theassembly of the head of bacteriophage T4 Nature 227, 680-685.[Medline]
Lee, J. A., Takai, A. and Allen, D. G. (1991). Okadaic acid, a protein phosphatase inhibitor, increases the calcium transients in isolated ferret ventricular muscle. Exp. Physiol. 76, 281-284.[Abstract]
Lee, T. H., Turck, C. and Kirschner, M. W. (1994). Inhibition of cdc2 activation by INH/PP2A. Mol. Biol. Cell 5, 323-338.[Abstract]
MacKintosh, C., Beattie, K. A., Klumpp, S., Cohen, P. and Codd, G. A. (1990). Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. FEBS Lett. 264, 187-192.[CrossRef][Medline]
Margolis, S. S., Walsh, S., Weiser, D. C., Yoshida, M., Shenolikar, S. and Kornbluth, S. (2003). PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation. EMBO J. 22, 5734-5745.
Masui, Y. and Markert, C. L. (1971). Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes. J. Exp. Zool. 177, 129-146.[Medline]
Maton, G., Thibier, C., Castro, A., Lorca, T., Prigent, C. and Jessus, C. (2003). Cdc2-cyclin B triggers H3 kinase activation of Aurora-A in Xenopus oocytes. J. Biol. Chem. 278, 21439-21449.
Mendez, R., Hake, L. E., Andresson, T., Littlepage, L. E., Ruderman, J. V. and Richter, J. D. (2000). Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA. Nature 404, 302-307.[CrossRef][Medline]
Merlevede, W., Vandenheede, J. R., Goris, J. and Yang, S.-D. (1984). Regulation of ATP, Mg-dependent protein phosphatase. Curr. Top. Cell. Reg. 23, 177-215.[Medline]
Sarkissian, M., Mendez, R. and Richter, J. D. (2004). Progesterone and insulin stimulation of CPEB-dependent polyadenylation is regulated by Aurora A and glycogen synthase kinase-3. Genes Dev. 18, 48-61.
Satinover, D. L., Leach, C. A., Stukenberg, P. T. and Brautigan, D. L. (2004). Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein. Proc. Natl. Acad. Sci. USA 101, 8625-8630.
Scrittori, L., Hans, F., Angelov, D., Charra, M., Prigent, C. and Dimitrov, S. (2001). pEg2 aurora-A kinase, histone H3 phosphorylation, and chromosome assembly in Xenopus egg extract. J. Biol. Chem. 276, 30002-30010.
Snyder, G. L., Girault, J. A., Chen, J. Y., Czernik, A. J., Kebabian, J. W., Nathanson, J. A. and Greengard, P. (1992). Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine. J. Neurosci. 12, 3071-3083.[Abstract]
Tsai, M. Y., Wiese, C., Cao, K., Martin, O., Donovan, P., Ruderman, J., Prigent, C. and Zheng, Y. (2003). A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly. Nat. Cell Biol. 5, 242-248.[CrossRef][Medline]
Walaas, S. I., Aswad, D. W. and Greengard, P. (1983). A dopamine and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 301, 69-71.[CrossRef][Medline]
Wasserman, W. J. and Masui, Y. (1974). A study on gonadotropin action in the induction of oocyte maturation in Xenopus laevis. Biol. Reprod. 11, 133-144.[Medline]